Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results

Corrado Marchini, Michele Acler, Marco A. Bolognari, Araldo Causero, Daniele Volpe, Dario Regis, Alessandra Rizzo, Raffaella Rosa, Roberto Eleopra, Paolo Manganotti

Research output: Contribution to journalArticle

Abstract

Objective: The aim of this study was to investigate the effect of botulinum toxin type A injection into the adductor muscles in reducing pain and improving joint mobility and quality of life in patients affected by hip osteoarthritis. Methods: A total of 39 outpatients, mean age 68 years (age range 41-82 years), were evaluated using the Harris Hip Score to test hip function, a visual analogue scale to measure pain intensity and the Short Form 36 (SF-36) questionnaire to assess patient well-being and quality of life at baseline, 2, 4 and 12 weeks after treatment with botulinum toxin type A. A total of 400 U of botulinum toxin type A (Dysport) was injected into the adductor longus muscle and the adductor magnus muscle. Results: The Harris Hip Score increased significantly after 2, 4 and 12 weeks (df 3, χ2 = 45.1; p2 = 27.8;/>

Original languageEnglish
Pages (from-to)691-693
Number of pages3
JournalJournal of Rehabilitation Medicine
Volume42
Issue number7
DOIs
Publication statusPublished - Jul 2010

Fingerprint

Type A Botulinum Toxins
Botulinum Toxins
Hip Joint
Hip
Muscles
Quality of Life
Hip Osteoarthritis
Arthralgia
Visual Analog Scale
Outpatients
Therapeutics
Pain
Injections

Keywords

  • Botulinum toxin
  • Hip osteoarthritis
  • Muscle
  • Pain

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation
  • Medicine(all)

Cite this

Marchini, C., Acler, M., Bolognari, M. A., Causero, A., Volpe, D., Regis, D., ... Manganotti, P. (2010). Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results. Journal of Rehabilitation Medicine, 42(7), 691-693. https://doi.org/10.2340/16501977-0546

Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint : Preliminary results. / Marchini, Corrado; Acler, Michele; Bolognari, Marco A.; Causero, Araldo; Volpe, Daniele; Regis, Dario; Rizzo, Alessandra; Rosa, Raffaella; Eleopra, Roberto; Manganotti, Paolo.

In: Journal of Rehabilitation Medicine, Vol. 42, No. 7, 07.2010, p. 691-693.

Research output: Contribution to journalArticle

Marchini, C, Acler, M, Bolognari, MA, Causero, A, Volpe, D, Regis, D, Rizzo, A, Rosa, R, Eleopra, R & Manganotti, P 2010, 'Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results', Journal of Rehabilitation Medicine, vol. 42, no. 7, pp. 691-693. https://doi.org/10.2340/16501977-0546
Marchini, Corrado ; Acler, Michele ; Bolognari, Marco A. ; Causero, Araldo ; Volpe, Daniele ; Regis, Dario ; Rizzo, Alessandra ; Rosa, Raffaella ; Eleopra, Roberto ; Manganotti, Paolo. / Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint : Preliminary results. In: Journal of Rehabilitation Medicine. 2010 ; Vol. 42, No. 7. pp. 691-693.
@article{eb06366a2f264c499a323e36312319ad,
title = "Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint: Preliminary results",
abstract = "Objective: The aim of this study was to investigate the effect of botulinum toxin type A injection into the adductor muscles in reducing pain and improving joint mobility and quality of life in patients affected by hip osteoarthritis. Methods: A total of 39 outpatients, mean age 68 years (age range 41-82 years), were evaluated using the Harris Hip Score to test hip function, a visual analogue scale to measure pain intensity and the Short Form 36 (SF-36) questionnaire to assess patient well-being and quality of life at baseline, 2, 4 and 12 weeks after treatment with botulinum toxin type A. A total of 400 U of botulinum toxin type A (Dysport) was injected into the adductor longus muscle and the adductor magnus muscle. Results: The Harris Hip Score increased significantly after 2, 4 and 12 weeks (df 3, χ2 = 45.1; p2 = 27.8;/>",
keywords = "Botulinum toxin, Hip osteoarthritis, Muscle, Pain",
author = "Corrado Marchini and Michele Acler and Bolognari, {Marco A.} and Araldo Causero and Daniele Volpe and Dario Regis and Alessandra Rizzo and Raffaella Rosa and Roberto Eleopra and Paolo Manganotti",
year = "2010",
month = "7",
doi = "10.2340/16501977-0546",
language = "English",
volume = "42",
pages = "691--693",
journal = "Journal of Rehabilitation Medicine",
issn = "1650-1977",
publisher = "Foundation for Rehabilitation Information",
number = "7",

}

TY - JOUR

T1 - Efficacy of botulinum toxin type a treatment of functional impairment of degenerative hip joint

T2 - Preliminary results

AU - Marchini, Corrado

AU - Acler, Michele

AU - Bolognari, Marco A.

AU - Causero, Araldo

AU - Volpe, Daniele

AU - Regis, Dario

AU - Rizzo, Alessandra

AU - Rosa, Raffaella

AU - Eleopra, Roberto

AU - Manganotti, Paolo

PY - 2010/7

Y1 - 2010/7

N2 - Objective: The aim of this study was to investigate the effect of botulinum toxin type A injection into the adductor muscles in reducing pain and improving joint mobility and quality of life in patients affected by hip osteoarthritis. Methods: A total of 39 outpatients, mean age 68 years (age range 41-82 years), were evaluated using the Harris Hip Score to test hip function, a visual analogue scale to measure pain intensity and the Short Form 36 (SF-36) questionnaire to assess patient well-being and quality of life at baseline, 2, 4 and 12 weeks after treatment with botulinum toxin type A. A total of 400 U of botulinum toxin type A (Dysport) was injected into the adductor longus muscle and the adductor magnus muscle. Results: The Harris Hip Score increased significantly after 2, 4 and 12 weeks (df 3, χ2 = 45.1; p2 = 27.8;/>

AB - Objective: The aim of this study was to investigate the effect of botulinum toxin type A injection into the adductor muscles in reducing pain and improving joint mobility and quality of life in patients affected by hip osteoarthritis. Methods: A total of 39 outpatients, mean age 68 years (age range 41-82 years), were evaluated using the Harris Hip Score to test hip function, a visual analogue scale to measure pain intensity and the Short Form 36 (SF-36) questionnaire to assess patient well-being and quality of life at baseline, 2, 4 and 12 weeks after treatment with botulinum toxin type A. A total of 400 U of botulinum toxin type A (Dysport) was injected into the adductor longus muscle and the adductor magnus muscle. Results: The Harris Hip Score increased significantly after 2, 4 and 12 weeks (df 3, χ2 = 45.1; p2 = 27.8;/>

KW - Botulinum toxin

KW - Hip osteoarthritis

KW - Muscle

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=77954665612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954665612&partnerID=8YFLogxK

U2 - 10.2340/16501977-0546

DO - 10.2340/16501977-0546

M3 - Article

C2 - 20603701

AN - SCOPUS:77954665612

VL - 42

SP - 691

EP - 693

JO - Journal of Rehabilitation Medicine

JF - Journal of Rehabilitation Medicine

SN - 1650-1977

IS - 7

ER -